Bharat Jodo Yatra: Shashi Tharoor said, ‘Converting the benefits of Bharat Jodo Yatra into votes…’

Bharat Jodo Yatra News: Congress leader Shashi Tharoor is often in headlines for his outspoken rhetoric. On Thursday, he gave his reaction regarding the Bharat Jodo Yatra. Along with this, he told what strategy Congress will have to adopt in the upcoming Lok Sabha elections.

The Congress leader said that people are very fond of the ongoing Bharat Jodo Yatra under the leadership of Rahul Gandhi. There is a wide-scale reaction regarding the yatra. But converting them into votes is the next challenge. The Congress leader said that it will not be easy to convert the response received from Bharat Jodo Yatra into votes. Along with this, it will not happen automatically.

Let us inform that Tharoor had recently contested for the post of Congress President but he lost to Mallikarjun Kharge. Tharoor said that his party would need to take other parties, especially regional parties, together to mount a challenge in the 2024 general elections.

Improvement in the image of Rahul Gandhi

News Reels

He told PTI here that he himself believes that the way Rahul Gandhi is being welcomed by the public, it is very beneficial for his image. He said that now the next challenge is to convert it into votes and it will not happen by itself.

What said about Kovid-19

Asked about the threat posed by COVID-19 to the yatra, Tharoor said the yatra would end in less than a month, on January 26, and so far the “messages” coming from experts have been quite reassuring. Huh.

He said that the variant causing a lot of damage in China has already been identified in India in June-July and no major disaster has happened. He said that the country still needs to be vigilant. Earlier this week, the Congress alleged that the government was using Covid as an excuse to stop the Bharat Jodo Yatra.

read this also: COVID 19: Corona negative report is necessary for passengers coming from 6 countries including China, health minister gave these instructions to pharmaceutical companies. big things


Leave a Comment